Tuesday, February 25, 2020 9:33:20 PM
I can talk to you about the differences of the common flu and the Coronavirus for hours.
Bottom line is that they have ammunition to fight the flu but they have nothing for the CoVid-19 so far.
it's true that most people can stay home and recover from it without doing anything but they are petrified that hospitals will be flooded with so many patients who would truly need care that they won't be able to handle them.
And that is where you can get worse, hospitals. So they are asking people in China and in Europe to stay home instead of going to hospitals unless they get really bad.
I wonder why you bought into VYST if you don't believe they have a viable product. They do have the product and the timing is right. If they have the funds and the knowledge to place in the market is another story.
Today's buying while the rest of the global markets are crashing (because of the virus concerns) is very encouraging. It happened because somebody knows that news is coming OR the company started a minor buyback to bring the pps back above 1c and maintain OTCQB status.
Let's see how it plays tomorrow...
Bottom line is that they have ammunition to fight the flu but they have nothing for the CoVid-19 so far.
it's true that most people can stay home and recover from it without doing anything but they are petrified that hospitals will be flooded with so many patients who would truly need care that they won't be able to handle them.
And that is where you can get worse, hospitals. So they are asking people in China and in Europe to stay home instead of going to hospitals unless they get really bad.
I wonder why you bought into VYST if you don't believe they have a viable product. They do have the product and the timing is right. If they have the funds and the knowledge to place in the market is another story.
Today's buying while the rest of the global markets are crashing (because of the virus concerns) is very encouraging. It happened because somebody knows that news is coming OR the company started a minor buyback to bring the pps back above 1c and maintain OTCQB status.
Let's see how it plays tomorrow...
Recent VYST News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM
